S3R

Stockholm3 Recommendation

It is the medical recommendation given based on a person's Stockholm3 risk score, which is a percentage indicating the risk of having clinically significant prostate cancer.

A risk value is classified into several different levels:

  • Low risk (0–3%): At a low risk, no further action is required, continued follow-up if necessary.
  • Normal risk (4–10%): At a normal risk, no immediate investigation is required, but monitoring may be considered depending on any symptoms and other factors.
  • Elevated risk (11–29%): When there is an increased risk, further investigation is recommended – e.g. MRI of the prostate or contact with a urologist.
  • High elevated risk (≥30%): Strong recommendation for investigation with MRI and possible biopsy in case of a higher elevated risk.
How is the recommendation used?

The recommendation facilitates decision-making about the next step for both the doctor and the individual.

Why is it important?

The recommendation functions as a scientifically based decision support in primary care and makes it possible to:

  • Identify those men who really need further investigation
  • Reduce the number of unnecessary biopsies
  • Improve accuracy compared to PSA testing

Remember: The final decision is always made in consultation with the doctor and may also include other information, such as prostate volume and imaging diagnostics.